CERTIFICATE

IMPACT FACTOR 2021

Subject Area

  • Life Sciences / Biology
  • Architecture / Building Management
  • Asian Studies
  • Business & Management
  • Chemistry
  • Computer Science
  • Economics & Finance
  • Engineering / Acoustics
  • Environmental Science
  • Agricultural Sciences
  • Pharmaceutical Sciences
  • General Sciences
  • Materials Science
  • Mathematics
  • Medicine
  • Nanotechnology & Nanoscience
  • Nonlinear Science
  • Chaos & Dynamical Systems
  • Physics
  • Social Sciences & Humanities

Why Us? >>

  • Open Access
  • Peer Reviewed
  • Rapid Publication
  • Life time hosting
  • Free promotion service
  • Free indexing service
  • More citations
  • Search engine friendly

Interaction of therapeutic drugs used for tackling covid-19 patients

Author: 
Poncheran Palanisamy, Venkateswaramurthy Nallasamy and Sambathkumar Ramanathan
Subject Area: 
Life Sciences
Abstract: 

Coronaviruses, such as HCoV 229E and HCoV OC43, were identified in the early 1960s. This coronavirus causes the most severe acute respiratory illnesses. SARS is a coronavirus that has been connected to a respiratory illness in the Middle East (MERS). The outbreak of Novel corona virus disease (COVID-19) was initially noticed in mid December, 2019,To improve the success rate of COVID-19treatment, several pharmacological approaches are proposed, and some clinical data are reviewed in the literature. Comorbid patients require many pharmacological therapies. Multiple medication use (polypharmacy) dramatically increases pharmacological adverse effects. As a result, diagnosis and treatment of drug-drug and disease-drug interactions are critical. When prescribing new drugs to COVID-19patients, clinicians should examine the likelihood of drug-drug and disease-drug interactions. Detecting drug-drug and disease-drug interactions of the medications utilized will thus be critical in the treatment of COVID-19. This article will concentrate on the drug-drug and disease-drug interactions of COVID-19 therapeutic medicines. Variations in the expression of a transporter are well recognized to result in changes in the PK/PD of the prescribed medication; hence, prescription medicine during inflammation may be a major contributor to inter-individual variability in drug efficacy and toxicity. It also highlighted the possibility of drug-drug and disease-drug interactions of the specified medicine in the treatment of COVID-19. It will aid in lowering risk in individuals with co-morbidities and providing better therapy with fewer adverse effects.

PDF file: 

CALL FOR PAPERS

 

ONLINE PAYPAL PAYMENT

IJMCE RECOMMENDATION

Advantages of IJCR

  • Rapid Publishing
  • Professional publishing practices
  • Indexing in leading database
  • High level of citation
  • High Qualitiy reader base
  • High level author suport

Plagiarism Detection

IJCR is following an instant policy on rejection those received papers with plagiarism rate of more than 20%. So, All of authors and contributors must check their papers before submission to making assurance of following our anti-plagiarism policies.

 

EDITORIAL BOARD

CHUDE NKIRU PATRICIA
Nigeria
Dr. Swamy KRM
India
Dr. Abdul Hannan A.M.S
Saudi Arabia.
Luai Farhan Zghair
Iraq
Hasan Ali Abed Al-Zu’bi
Jordanian
Fredrick OJIJA
Tanzanian
Firuza M. Tursunkhodjaeva
Uzbekistan
Faraz Ahmed Farooqi
Saudi Arabia
Eric Randy Reyes Politud
Philippines
Elsadig Gasoom FadelAlla Elbashir
Sudan
Eapen, Asha Sarah
United State
Dr.Arun Kumar A
India
Dr. Zafar Iqbal
Pakistan
Dr. SHAHERA S.PATEL
India
Dr. Ruchika Khanna
India
Dr. Recep TAS
Turkey
Dr. Rasha Ali Eldeeb
Egypt
Dr. Pralhad Kanhaiyalal Rahangdale
India
DR. PATRICK D. CERNA
Philippines
Dr. Nicolas Padilla- Raygoza
Mexico
Dr. Mustafa Y. G. Younis
Libiya
Dr. Muhammad shoaib Ahmedani
Saudi Arabia
DR. MUHAMMAD ISMAIL MOHMAND
United State
DR. MAHESH SHIVAJI CHAVAN
India
DR. M. ARUNA
India
Dr. Lim Gee Nee
Malaysia
Dr. Jatinder Pal Singh Chawla
India
DR. IRAM BOKHARI
Pakistan
Dr. FARHAT NAZ RAHMAN
Pakistan
Dr. Devendra kumar Gupta
India
Dr. ASHWANI KUMAR DUBEY
India
Dr. Ali Seidi
Iran
Dr. Achmad Choerudin
Indonesia
Dr Ashok Kumar Verma
India
Thi Mong Diep NGUYEN
France
Dr. Muhammad Akram
Pakistan
Dr. Imran Azad
Oman
Dr. Meenakshi Malik
India
Aseel Hadi Hamzah
Iraq
Anam Bhatti
Malaysia
Md. Amir Hossain
Bangladesh
Ahmet İPEKÇİ
Turkey
Mirzadi Gohari
Iran